Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Pisetsky Sells 36,241 SI-BONE Shares at $24.8007

Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Officer of SI-BONE, Inc., filed a Form 4 on November 6, 2026, disclosing a sale of 36,241 shares of common stock on November 4, 2026, pursuant to a Rule 10b5-1 trading plan.

Anjali Anand | 06 November 2026

Laura Francis Sells 75,000 SI-BONE Shares at $25.30

SI-BONE, Inc. Chief Executive Officer Laura Francis filed a Form 4 on November 6, 2026, disclosing the sale of 75,000 shares of common stock on November 4, 2026, pursuant to a Rule 10b5-1 trading plan.

Vinay Lochav | 06 November 2026

Walter Klemp RSU Vesting: 57 Shares, 14 Withheld for Tax

Walter V. Klemp, CEO, President, and Director of Moleculin Biotech, Inc. (NASDAQ:MBRX), filed a Form 4 on November 6, 2026, disclosing transactions dated November 4, 2026, related to the vesting of restricted stock units.

Aakashdeep | 06 November 2026

Donald Picker RSU Vest and Tax Withholding at Moleculin Biotech

Moleculin Biotech, Inc. Chief Science Officer Donald H. Picker filed a Form 4 on November 6, 2026, reporting transactions in common stock and restricted stock units dated November 4, 2026, on NASDAQ:MBRX.

Manish Choudhary | 06 November 2026

Moleculin Biotech CFO Foster RSU Vesting, 41 Shares, Nov 4

Jonathan P. Foster, Chief Financial Officer of Moleculin Biotech, Inc. (NASDAQ:MBRX), filed a Form 4 on November 6, 2026, reporting transactions dated November 4, 2026, related to the vesting of restricted stock units.

Vinay Lochav | 06 November 2026

Ingrid Burton Receives and Vests RSUs at Extreme Networks

Director Ingrid Burton of Extreme Networks Inc filed a Form 4 with the SEC on November 6, 2026, reporting both the vesting of existing restricted stock units and the grant of new restricted stock units on November 4, 2026.

Shwetambri Chauhan | 06 November 2026

Ryan King Sells 63,382 Chime Shares on Nov 5, 2026

Ryan A. King, Co-Founder, Director, and Officer of Chime Financial, Inc. (NASDAQ:CHYM), filed a Form 4 on November 6, 2026, disclosing transactions in Class A Common Stock and Class B Common Stock dated November 5, 2026.

Anjali Anand | 06 November 2026

Foster Sells Over 31,000 HCA Shares in Nov. 4-6 Transactions

Jon M. Foster, Executive Vice President and Chief Operating Officer of HCA Healthcare, Inc. (NYSE:HCA), filed a Form 4 on November 6, 2026, disclosing a series of common stock transactions dated November 4 and November 6, 2026.

Aakashdeep | 06 November 2026

Moreland Sells 3,500 Abbott Shares at $116 on Nov. 5

Mary K. Moreland, Executive Vice President of Abbott Laboratories, filed a Form 4 on November 6, 2026, disclosing a sale of common shares on November 5, 2026.

Vinay Lochav | 06 November 2026

Saba Capital Buys 28,208 JOF Shares at $10.61

Saba Capital Management, L.P. filed a Form 4 on November 6, 2026, disclosing a purchase of common stock in Japan Smaller Capitalization Fund Inc (NYSE:JOF) on November 5, 2026.

Shwetambri Chauhan | 06 November 2026
Support

Hi! How can we help you today?

Loading…